New insights in complex drug products for development and production (morning) / Advancing complex drug products through regulatory innovation (afternoon)
Recent developments in innovative technologies like Advanced Therapy Medicinal Products (ATMPs) and Nano-medicines provide new opportunities to address the increasing demands of an aging population, as well as for diseases with high unmet medical needs.
Despite considerable research and development activity only a limited number of ATMPs and Nano-medicines have been approved in the European Union. The road from development to approval pose many challenges for scientist, developers and regulators and ask for collaborative opportunities to meet those challenges, which we will discuss in two sessions.
Speakers will be announced shortly